Use of caffeic acid phenethyl ester and cortisone may prevent proliferative vitreoretinopathy

By Yusuf Turkoz   Hamdi Er   Mehmet Borazan   Harun Y  

Mediators of Inflammation, Vol. 13, Iss. 2, 2004-04 ,pp. : 127-130

Informa Healthcare

Access to resources Recommend Favorite

Defining the seriousness of proliferative vitreoretinopathy by aspiration of cytokines from the anterior chamber

By Rusnak Stepan   Vrzalova Jindra   Hecová Lenka   Kozova Marketa   Topolcan Ondrej   Ricarova Renata  

Biomarkers in Medicine, Vol. 7, Iss. 5, 2013-10 ,pp. : 759-767

Future Medicine

Access to resources Recommend Favorite

Effect of different fixative solutions on eyes with experimental proliferative vitreoretinopathy

By  

INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (ELECTRONIC), Vol. 96, Iss. 2, 2015-04 ,pp. : 103-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemokine CXCL‐1: activity in the vitreous during proliferative vitreoretinopathy

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 181, Iss. 2, 2015-08 ,pp. : 338-342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Procalcitonin as a marker of postoperative complications

By Kindberg Boysen A.   Madsen J. S.   Jørgensen P. E.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 65, Iss. 5, 2005-08 ,pp. : 387-394

Informa Healthcare

Access to resources Recommend Favorite